CS logo
small CS logo
Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie

Heidelberg, Germany

About Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


During the past decade, Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


According to Clinical.Site data, the most researched conditions in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie" are "Acute Lymphoblastic Leukemia, Pediatric" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie" in a lesser frequency.

Clinical Trials Intervention Types at Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


Most popular intervention types in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "6-Mercaptopurine" (1 trials), "Blinatumomab" (1 trials), "Bortezomib" (1 trials), "Cyclophosphamide" (1 trials) and "Cytarabine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


The vast majority of trials in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie" are 2 trials for "All" genders.

Clinical Trials Status at Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie


Currently, there are NaN active trials in "Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".